Literature DB >> 8521767

New approaches to the prevention of atherosclerosis.

M Naito1, T Hayashi, A Iguchi.   

Abstract

In recent years, remarkable progress has been made in the prevention and treatment of atherosclerosis. However, much of the research has been devoted to the investigation of lipid metabolism and lipid-lowering drugs. This review highlights some recent topics in both experimental and clinical investigations, with emphasis on studies other than those on lipid-lowering drugs. These topics include oxidative modification of lipoproteins, hyperfibrinogenaemia, hyperhomocysteinaemia, female sex hormones and endothelium-derived relaxing factor (or nitric oxide). Some of these approaches have already been applied in the clinic.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8521767     DOI: 10.2165/00003495-199550030-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  143 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits.

Authors:  A Daugherty; B S Zweifel; G Schonfeld
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

3.  Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B.

Authors:  A Chait; R L Brazg; D L Tribble; R M Krauss
Journal:  Am J Med       Date:  1993-04       Impact factor: 4.965

4.  Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine.

Authors:  E N Frankel; J Kanner; J B German; E Parks; J E Kinsella
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

5.  Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies.

Authors:  M Aviram; G Dankner; U Cogan; E Hochgraf; J G Brook
Journal:  Metabolism       Date:  1992-03       Impact factor: 8.694

6.  The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E.

Authors:  E E Windler; P T Kovanen; Y S Chao; M S Brown; R J Havel; J L Goldstein
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

7.  Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene.

Authors:  P D Reaven; A Khouw; W F Beltz; S Parthasarathy; J L Witztum
Journal:  Arterioscler Thromb       Date:  1993-04

8.  Vitamin E consumption and the risk of coronary disease in women.

Authors:  M J Stampfer; C H Hennekens; J E Manson; G A Colditz; B Rosner; W C Willett
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

9.  The natural history of homocystinuria due to cystathionine beta-synthase deficiency.

Authors:  S H Mudd; F Skovby; H L Levy; K D Pettigrew; B Wilcken; R E Pyeritz; G Andria; G H Boers; I L Bromberg; R Cerone
Journal:  Am J Hum Genet       Date:  1985-01       Impact factor: 11.025

10.  Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

Authors:  A A Nabulsi; A R Folsom; A White; W Patsch; G Heiss; K K Wu; M Szklo
Journal:  N Engl J Med       Date:  1993-04-15       Impact factor: 91.245

View more
  7 in total

Review 1.  Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia.

Authors:  J C Adkins; D Faulds
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

Review 2.  HMG-CoA reductase inhibitors and myotoxicity.

Authors:  M Ucar; T Mjörndal; R Dahlqvist
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

Review 3.  Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.

Authors:  K L Goa; L B Barradell; G L Plosker
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

4.  Hyperhomocysteinemia and cardiovascular disease: The nutritional perspectives.

Authors:  R Pandey; S Gupta; H Lal; H C Mehta; S K Aggarwal
Journal:  Indian J Clin Biochem       Date:  2000-08

Review 5.  Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemia.

Authors:  Gillian M Keating; Douglas Ormrod
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Effects of gender and gonadectomy on growth and plasma cholesterol levels in pigs.

Authors:  Chong-Eon Lee; Nam-Young Kim; Kyu-Il Kim
Journal:  Nutr Res Pract       Date:  2009-03-31       Impact factor: 1.926

7.  Inhibitory Effect of Aqueous Extract of Stem Bark of Cissus populnea on Ferrous Sulphate- and Sodium Nitroprusside-Induced Oxidative Stress in Rat's Testes In Vitro.

Authors:  Seun F Akomolafe; Ganiyu Oboh; Afolabi A Akindahunsi; Ayodele J Akinyemi; Oluwatosin G Tade
Journal:  ISRN Pharmacol       Date:  2013-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.